Skip to main content
. 2021 Apr 20;4:486. doi: 10.1038/s42003-021-02011-6

Fig. 5. Severe Covid-19 patients present higher levels of anti-spike IgG antibodies compared to moderate Covid-19 patients.

Fig. 5

a gMFI values obtained by C19BA (left) and OD values obtained by ELISA (right) corresponding to levels of IgG against RBD, S1, and N for the indicated cohorts. b Representative dot plots obtained by C19BA showing IgG levels for COVID negative (n = 18), mild/moderate COVID (n = 18), and severe COVID serums (n = 16) obtained from PCR+ individuals at the time of hospital admission. Statistical analyses were performed using two-way ANOVA. Asterisks represent p values (****p < 0.0001, *p < 0.05). Horizontal lines represent median values.